HAVE
HAVE APPOINTMENTS WITH
THOSE
THOSE PLACE Y A ATT CONTACT THEM, THOUGH THEY HV
+@
CONTACT THEM, THOUGH THEY HV PROBABLY ALREADY CONTACE O
AT THIS POINT.
I KNOW YOU GUYS HAVE A LOT OF
QU+@ESTIONS, SO I WOULD LIKE TO
BRING IN AN EXPERT.
I'M JOINED BY THE +@DIRECTOR OF
INFECTIOUS DESSA+@ SOT
SHORE HEALTH AND A REG+@ULAR
CONTRIBU+@TOR TO ABC NEWS.
GOOD TO SEE YOU AGAIN.
I THINK ONE OF T+@HE MOST COMMON
QUESTIONS RIGHT NW I HS
PEOPLE H GO, "OH, MY GOSH, I
JU+@ST GOT THE VACCINE YESTERA
OR THE AY OOH A
BEFORE.
BEFORE.
BEFORE. WHAT SHOULD I DO NOW?"
>> THE FIRST THING IS WE NEEDT
TAKE A+@ DEEP B+@REATH.
THE BOTTOM EI THIS SUPER
RARE.
RARE.
RARE. THESE UNUSUAL CLOTS ARE
OCCURRING IN LESS THAN ONE PER
+@
+@ BILLION PEOPLE WHO RECEIVE THE
VACCINE.
VACCINE.
VACCINE. THE MAJORITY OPEOL -- VERY
SAFE, VERY EFFECTIVE VACCINE,
+@
SAFE, VERY EFFECTIVE VACCINE, BUT I THINK E SAFETY PAUSE IS
IMPORTANT BECAUSE IT EEM O BE
AFFECTING A YOUNGER POPULATION,
FEMALES M N MALES, SO WE
+@
FEMALES M N MALES, SO WE WANT+@ TO MAKE SURE THIS VACCN
IS OK FOR ALL AGE GROUPS, AND IF
+@
IS OK FOR ALL AGE GROUPS, AND IF NOT, THE FDA AND CDC WILL REALLY
CRUNCH HES NUMBERS+@ AND FIGURE
OUT, YOU +@KNOW, HULD W
--
-- SONIA:
-- SONIA: I THINK WHAT IS
INTERESTIN AS WE ARE P+@AUSING
NOW AFTER SIX INSTANCES OF THIS
TYPE OF CLOTTN.
I'M WONDIW NOW?
+@
I'M WONDIW NOW? WHAT+@ IS THE PROPE TIMEFRAME TO
SAY NOW WE'VE GOT TO PAUSE
BECAUSE IT A BEENSI PEOPLE?
>> IT IS AN IMPORTANT POINT
BECAUSE REMEMBETHPAUE IS
NOT JUST ABOUT XOPLE, BUT
IF +@YOU REMEMBER, HSRZECA
+@
+@ VACCINE HAS SDME RARE
CLOTTING AS WELL, AND THERE'S
SOME SIMILARITIESBTE HE
PLATFORM OSACA AND
JOHNSON & JON.
THEY ARE BOTH VIRAL VECTOR
VACCINES, SO ONE OF THE THINGS
THE CDC AND FDA ARE GOINGT
LOOK AT HIS IS THERE SOMETHIG
ABOUT THIS TYPE OF PLATFORM THAT
INCREASES THE RISK OF THES+@E
UNUSUAL CLOTS, EVEN THOUGH, OF
COURSE, AGAIN, IT IS SUPER RAR.
SONIA: I WAS ON A MEDIA CALL A
COUPLE OF HOURS AGO WITH THE FDA
AND CDC.
AND CDC.
AND CDC. WE A+@RE SAYING IT IS RARE, BUT
TWO PEOPL JUST BACK -- BUT TO
PEOPLE LISTENING WONDERING HOW
DO THEY KNOW IF IT WILL AFFECT
THEM, THEAATAHSTOY
THEM, THEAATAHSTOY OF BLOO LI THATWL
C+@ONTRIBT T.
C+@ONTRIBT T. >> IT DOES SEEM TO BE A
MECHANISM WHERE THESE RARE
EVENTS ARE +@OCITD WITH LOW
PLATELETS.
PLATELETS. WH+@AT IS +@UNUSUAL IS PLATELT R
SUPPOSED OOLIG FOR
CLOCK, BUT OCCASIONALLY, THERE
ARE CONDITI RO A GET
A+@ LOW PLATELET+@ NUBRAD HAVE A
PREDISPOSITION TO CLOTN,AD
THAT IS WHAT MAY BE HAPPENING
+@HERE.
+@HERE.
+@HERE. IT ALSO LOOSK OMEO THESE
PATIENTS HAVE ANTIBODIES
DIRECTED AGAINST THAT PLATELET,
SO THERE MAY BE A CONNECTION
DIRECTED AGAINST THAT PLATELET, SO THERE MAY BE A CONNECTION+@
+@
+@ BETWEEN THECLOTN EARE
S+@EEING IH THE ASTRA+@ZENECA
VACCINE AND THE CLOTTING WE ARE
SEEING WITH THE J&J VACCINE.
THAT STILL NEEDS TO BE
ELUCIDATED.
ELUCIDATED. THAT IS NOT CONFIRMED.
SONIA: I KNOW WE ARE TALKING
ABOUT TIML.
ABOUT TIML. HOW LONG SHOULD PEOPLE BE
CONCERNED ABOUT POTENIL
SYMPTOMS POPPING UP?
THE FDA AND CDC SAYING THE
MEDIAN TIME I ABOUT NINE DAYS.
>> RIGHT, SO SO FAR ALL THE
CASES THAT HAVE OCCURRED NTE
UNITED STATES HAV CURD
WITHIN WE TIME PERO.
THAT'S WITH THE J&J VACCINE
INDUCED CO THINK MOST
PEOPLE, AGAIN, THERE HAVE BEEN
NEARLY 7 MILLION J&J DOSES THAT
HAVE BEEN AMNISEE TO DATE,
SO WE ARE TALKING ABOUT SIX OVER
7 MILLION.
7 MILLION. I WANT PEOPLTEEP THAT IN
PERSPECTIVE.
PERSPECTIVE. EVEN WHEN TAKE PENICILLIN,
THERE IS A RK OF SEVERE
ANAPHYLAXIS IN ABOUT ONE IN
10,000 PEOPLE, SOJS OPT
THAT IN PERSPECTIVE.
IT I+@S SOMETHING WE REALLY WANT
+@TO SCRUTINIZE, AND I THINK TS
WONDERFUL THE FDA AND CDC DID
PUT A SAFETY PAUSE ON THAT, AND
I THINK IT MAKES SENSE, BUT SOME
OTHER C+@OUNTRIES IN H UOEN
UNION HVE SAID THE BENEFITS OF
THE ASTRAZENECA VACCINE OUTWEIGH
THE RISKS B YV CHANGED
SOME OF THE AGE ELIGIBILITY TO
AN OLDER AGE GROUP AND ARE
LOOKING FOR THE YOUNGER PEOPLE
TO GET OTEY O+@F VACCINES.
THAT IS THE TYP F WORK THE FDA
AND CDC ARE GOING TO DO OVER THE
NEXT FEW DS
SONIA: FINALLY, I WANT TO MAKE
AN IMPORTANT DISTINCTION BETWEEN
SIDE EFFECTS ORSM FTE
SYMPTOM EOE WANT TO BE
CONCERNED ABOUT WT EAD +@TO
W+@HAT THEY ARE HEARING TODAY.
WE CAN SEE INSTANCES OF FATIGUE
OR FEVER OR EVEN A MILD HEADACHE
FOR A COUPLFDY FE
RECEIVING ONE OF THESE VACCINES,
BUT THAT IS DIFFEETFO WHAT
WE ARE TALKING ABOUT TODAY.
>> I'M REA APP O D
THAT BECAUSE IT IS SO IMPORTANT.
EVEN AS CLINICAL TRIALS, AT
LEAST 5% OF P+@ATIENTS DEEOE
HEADACHES
HEADACHES
HEADACHES 350,000 PEOPLE HAVE HEADAC+@HES
AFTER RECE+@IVING THE J&J VCIE
350,000 PEOPLE HAVE HEADAC+@HES AFTER RECE+@IVING THE J&J VCIE+@
+@
+@ THAT
+@ THAT IS TO BE EXPECE.
WHAT IS INTERESTING IS THE J&J
VA+@CCINE OVEALHS LESS SIDE
EFFECTS+@ OVERALL AFTER TE SHOT
THAN THE MESSENGER RNA VACCINES,
PFIZER AND METRI A, SO YOU
ARE RIG+@HT -- WEHV OKE
THESE TIG IN PERSPECTIVE AND
REALIZE THAT FOR OT